• Set Text Size  
       

What’s New in MG Research

Wondering about the most recent progress in Myasthenia Gravis treatments research and clinical trials?

You’re invited to join our “What’s New in MG Research” webinar to learn about the latest research results, key clinical trial phases, and current outcomes from top research trials taking place right now. MGFA is offering this online webinar program series to anyone interested in learning more about this ongoing MG research in investigative therapies. We hope you’ll register for the latest update.

 

What’s New in Anti-Acetylcholine (AChR) Receptor Antibody-Positive Generalized Myasthenia Gravis (gMG)

Date/Time: Tuesday, November 9th 2021 at 3:00 p.m. Eastern

This webinar will provide the latest information about investigational therapies being studied by Alexion, AstraZeneca Rare Disease for the treatment of anti-AChR receptor antibody-positive gMG. Updates will be given on a Phase 3 clinical trial as well as other molecules in development.

Register for This Webinar

 

 

Adverse Event Unit Project

Date/Time: Tuesday, December 14th 2021 at 3:00 p.m. Eastern
Presenter: Dr. Michael K. Hehir, University of Vermont Medical Center, MGFA Partner in MG Care

There is increasing emphasis on side effect burden for patients with myasthenia gravis as new treatments are approved and we attempt to understand differences among these treatments. This webinar will provide the latest information about Adverse Event Unit project designed to better measure the burden of MG treatment related to adverse events. Dr. Hehir will provide an update on this research project which was a recipient of MGFA pilot grant funding in 2020.

Register for This Webinar

 

 

Webinar Replays

     

     

     

     

 

We Thank Our Generous Sponsors

                         
            

 

A World Without MG